Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Volvo Buses wins Digital Communications Award 2018

Facing tough competition from several of Europe’s foremost companies, Volvo Buses took first place in the product campaigns category of the prestigious Digital Communications Award 2018 competition. Volvo Buses competed with its innovative “Light the Lights” introduction campaign for the company’s new electric bus, the Volvo 7900 Electric. The award was handed over at a ceremony in Berlin on September 28.Digital Communications Award has been spotlighting and rewarding innovative communication in digital channels since 2011. All told, there were more than 700 entries to the competition this

Senior Management change at Handelsbanken

Dan Lindwall has been appointed Acting Head of Handelsbanken Markets & Asset Management. He is currently Head of Handelsbanken International, which has operations in some 20 countries. In his new position, Dan Lindwall will be a member of the Group’s Senior Management.  Per Elcar, Head of Handelsbanken Markets & Asset Management, a part of Handelsbanken Capital Markets, has resigned from his position and his role in the Group’s Senior Management. He will take up another position at the Bank. “A new leadership will facilitate the work to address a culture of abusive treatment and the

Primary insider disclosure

Eirik Eide, Chief Financial Officer in Ocean Yield ASA, has transferred 44,700 shares that is owned by Mr. Eide personally to his wholly owned company Kleiver Invest AS. Following this transaction Mr. Eide’s direct and indirect shareholding in Ocean Yield ASA remains unchanged with 335,051 shares. The transaction was based on the closing price as of 2 October 2018. This information is subject of the disclosure requirements pursuant to section 5-2 and 4-2 of the Norwegian Securities Trading Act.

Bittium Wireless Ltd, a subsidiary of Bittium Corporation, and Finnish Defence Forces prepare a Framework Agreement on Bittium Tough Comnode terminals

The Finnish Defence Forces have been authorized to sign a Framework Agreement on the purchase of versatile Bittium Tough Comnode™ terminalsStock exchange release Free for publication on October 3, 2018 at 9.32am (CEST +1) Bittium Wireless Ltd, a subsidiary of Bittium Corporation, and Finnish Defence Forces prepare a Framework Agreement on Bittium Tough Comnode™ terminals The Finnish Defence Forces have been authorized to sign a Framework Agreement on the purchase of versatile Bittium Tough Comnode™ terminals Oulu, Finland, October 3, 2018 – The Finnish Minister of Defence Jussi

University of Oxford Initiates Research on Endocrinology of Human Lactation

The Family Larsson-Rosenquist Foundation (FLRF) has awarded £2.9 million to the Nuffield Department of Women’s & Reproductive Health at the University of Oxford to establish a research centre focused on studying the endocrinology of human lactation.Breast milk is known to provide the best source of nutrition for newborns and children; it also has a positive impact on their long-term health and development. Although valuable research has already been conducted in the field of human lactation, many questions remain unanswered – such as how hormones control milk production and weaning, and

Brighter receives SEK 29M from the company's management, board and key personnel.

The exercise period for Brighter's management, board and key personnel incentive programs 2014/2017 Series I & II and 2015/2018 Series I & II is now completed. The company has received a total of SEK 29,369,024 through the programs. "This capital injection means that we with force can take on and maximize the commercialization of Actiste in, among other markets, the United Arab Emirates,” says Truls Sjöstedt, Brighter’s CEO and founder. This exercise will increase the number of shares in Brighter with 3,383,136. For further information, please contact: Truls Sjöstedt, CEO

IRRAS TO PARTICIPATE IN KEY UPCOMING NEUROSURGERY CONFERENCES

- IRRAflow® system to be demonstrated at both CNS and EANS tradeshows in October Stockholm, Sweden, October 3, 2018 – IRRAS AB (“IRRAS”), a commercial-stage medical technology company focused on developing and commercializing transformative treatments to manage intracranial fluids, today announced that the company will be participating in the Congress of Neurological Surgeons (CNS) 2018 Annual Meeting from October 6 – 10 in Houston, TX, and the 18th EANS European Congress of Neurosurgery from October 21 – 25 in Brussels, Belgium. These two meetings are key forums for the latest research

Ingalls Shipbuilding orders automated PEMA Bulkhead production line to Pascagoula shipyard

Pemamek Ltd. and Mississippi-based Ingalls Shipbuilding have formalized a future working collaboration as Ingalls places an order for automated PEMA Bulkhead production line. The agreement is a continuum for the large-scale PEMA welding automation solutions delivered in 2017. (Press Release, Pemamek, 2017). PEMA Bulkhead production line will be delivered as a turn-key installation. The solution consists of integrated milling, advanced one-sided welding station with MAG process, profile and T-beam assembling and tack-welding solutions, as well as two robotized welding portals

Invitation to the media and capital market in conjunction with Investor’s Interim Management Statement January-September 2018

Investor’s meeting for financial analysts and the media will be held in Stockholm on Wednesday, October 17, 2018, 10:00 CET at Arsenalsgatan 8C. President and CEO Johan Forssell and CFO Helena Saxon will present the Interim Management Statement January-September 2018. The presentations will be in English and webcasted through www.investorab.com, where you can also ask questions. If you prefer to listen to the presentation, please call +44 203 364 5374, +1 855 753 2230 or +46 8 5055 6474. The presentation material will be published on our website after the meeting, where you can also

Year-End Report 17/18

September 2017 – August 2018, Diamyd Medical AB (publ), Fiscal year 2017/2018Strong results from DIAGNODE-1Diamyd Medical’s B-share is traded on Nasdaq First North under the ticker DMYD B. Further information is available on https://www.diamyd.com Fourth quarter, June 1– August 31, 2018 ·  Net result amounted to MSEK -11.7 (-6.5). The change compared with the previous year relates to the DIAGNODE-2 trial that started during the financial year. ·  Result per share amounted to SEK -0.2 (-0.1) ·  Cash flow from operating activities amounted to MSEK -9.0 (-9.8) ·  Liquid

KUTSU NITRO GAMES OYJ:N YLIMÄÄRÄISEEN YHTIÖKOKOUKSEEN / NOTICE TO THE EXTRAORDINARY GENERAL MEETING OF NITRO GAMES OYJ

Nitro Games Oyj:n osakkeenomistajat kutsutaan yhtiön ylimääräiseen yhtiökokoukseen, joka pidetään 24.10.2018 klo 13.00 alkaen (Suomen aikaa) osoitteessa Radisson Blu Plaza/Boardroom, Mikonkatu 23, 00100 Helsinki, Suomi. Kokoukseen ilmoittautuneiden vastaanottaminen ja äänestyslippujen jakaminen aloitetaan klo 12.30. The shareholders of Nitro Games Plc are summoned to the company’s Extraordinary General Meeting to be held on 24 October 2018 at 13:00 (Finnish time) at Radisson Blu Plaza/Boardroom, Mikonkatu 23, 00100 Helsinki, Finland. The reception of persons who have registered for the

Avanza’s now offers margin lending at 0% interest

Avanza is improving its Super Loan and cutting the lowest interest rate on margin lending to 0%.Super Loan is a popular product among many of Avanza’s customers who want to buy more securities by using their existing holdings as collateral. Leveraging securities entails a risk, but at the same time provides greater savings flexibility. “The negative interest rate has given us an opportunity to improve our margin lending terms. Since we borrow from our customers without paying interest, we feel we can lend to them at no interest if the risk is low,” says Rikard Josefson, CEO of Avanza.

Tecnotree renews maintenance contract with NetOne

Tecnotree CorporationPress Release3  October 2018 at 9.00 a.m. EESTTecnotree renews maintenance contract with NetOne  Tecnotree, a global provider of telecom IT solutions, today announces that it has been awarded a maintenance contract by NetOne, a state owned Telecom operator in Zimbabwe. Tecnotree applications have enhanced NetOne’s revenues and added value to its business over the years. In order to ensure continued and sustainable growth, NetOne relied on Tecnotree to provide continuous support to its platforms, and provide world class services to their end customers. Under

Follicum AB on schedule to present top-line results from the phase IIa study with FOL-005 for hair growth at the end of October 2018

Follicum AB ("Follicum") reported on August 28, 2018 that all patients in the phase IIa study with FOL-005 for hair growth had completed their treatment. Today Follicum, in according with the company's communicated time lines, announced it expects to present top-line results from the Phase IIa study by the end of October 2018.Follicum's Phase IIa study has been conducted at the CRC in Berlin and bioskin, Hamburg, Germany. The Phase IIa study aims to investigate the safety and therapeutic effect of four different doses of FOL-005 and placebo, administered as injections into the patient’s

Borr Drilling Limited (BDRILL) – Activation of four additional jack-up drilling rigs

Following its recent board meeting, Borr Drilling Limited (“Borr”) has decided to start the activation of four additional newbuild jack-ups. This decision is made on the back of Borr's previously announced success in securing commitments for three of its newbuild units and its North Sea based jack-up "Ran", all of which are currently undergoing (re)activation and have been awarded LOIs. These rigs are expected to commence work in the first half of 2019. Supported by the strong increase in direct customer requests and the material increase in tender activity of approximately 50% year to

Initiator Pharma gets approval to continue the IPED2015 trial

Initiator Pharma A/S, a biotech company developing a novel treatment of erectile dysfunction, today announced that it has received approval for an amendment to the clinical trial protocol to the Medicines & Healthcare products Regulatory Agency, MHRA, UK as well as the Ethics Committee, EC.‘We are really pleased with the fast approval of the amendment, and noticeable we obtained the go-head without any questions to the content. We have demonstrated that despite this unforeseen incident we are now allowed and capable to continue the study with our qualified CRO, MAC Clinical Research ’says

Composition of Exel Composites Plc’s Nomination Board

EXEL COMPOSITES PLC       STOCK EXCHANGE RELEASE      3 October 2018 at 09:00 EETAccording to the resolution of Exel Composites’ Annual General Meeting held on 22 March 2018, the company’s shareholders’ Nomination Board consists of the representatives of the four largest shareholders and of the Chairman of the Board of Directors, acting as an expert member. The largest shareholders entitled to appoint members to the Nomination Board were determined on the basis of the registered holdings in the company’s shareholder register held by Euroclear Finland Oy on 30 September 2018. Shareholders

Bravida strengthens electrical market position in Swedish Skellefteå

Bravida is acquiring Nyheden Fällfors El AB, bolstering its electrical market position in Skellefteå – a region of strong growth in northern Sweden. The acquired business offers services in service, installation and automation.Nyheden Fällfors El was founded in 1978 and operates in Swedish Skellefteå with surroundings. The company has 27 employees and annual sales of approximately SEK 40 million.“We regard Skellefteå as a highly attractive market where Bravida is represented within electrical, ventilation, heating and plumbing. The acquisition means that we are strengthening our

Nitro Games’ Board of Directors has resolved, subject to approval on an Extraordinary General Meeting, on a directed share issue of SEK 47.4 million

The Board of Directors of Nitro Games Oyj (publ) (“Nitro Games” or the “Company”) has resolved, subject to the approval by shareholders at an Extraordinary General Meeting (the “EGM”), on a directed new issue of 998,000 shares at a subscription price of SEK 47.5 per share (the “Directed Share Issue”), which is expected to raise proceeds to the Company of SEK 47.4 million before issue costs. The proceeds will primarily be used for marketing and scaling up of the Company’s new game Heroes of Warland (”HoW”).   The Board of Nitro Games has resolved, subject to the approval by shareholders

Raketech continues to optimise its capital structure

With the intention to optimise its capital structure, Raketech has today repaid EUR 15.5 million of the current loan under its current credit facility. As a result of the payment, Raketech will decrease its financial expense attributable to borrowing with EUR 0.5 million approx. per quarter.Following the payment, the remaining outstanding debt within the credit facility amounts to EUR 7.7 million, which Raketech aims to settle in full over time. Raketech continues to pursue its active M&A strategy and is engaged in discussions with several acquisition candidates. Andreas Kovacs, Raketech’

Results from the anaGO study – a phase 2 study with anakinra in patients with acute gout

Swedish Orphan Biovitrum AB (publ)  (Sobi™) releases the primary efficacy results from the phase 2 study with anakinra in patients with acute gout – the anaGO study. For the primary endpoint of patient assessed pain intensity in the most affected joint there was a substantial reduction from baseline, both following treatment with anakinra and the comparator triamcinolone. There was a clinically meaningful pain reduction with anakinra of around 50% and in line with expectations of IL-1 blockade in this disease. No statistically significant difference between the two

Solteq Plc: Invitation to the Extraordinary General Meeting

Solteq Plc Stock Exchange Bulletin 3.10.2018 at 9.00 am Shareholders of Solteq Plc are hereby invited to the Extraordinary General Meeting to be held on Thursday, 25 October 2018 at 12.30 pm in the Break Sokos Hotel Flamingo, address Tasetie 8, 01510 Vantaa. The reception of the shareholders registered for the meeting begins at 12.00 pm. A. Matters on the agenda of the General Meeting At the general meeting, the following matters will be considered: 1. Opening of the meeting 2. Calling the meeting to order 3. Election of persons to scrutinize the minutes and to supervise

Tikkurila efficiency program will result in the reduction of 500 employees

Tikkurila OyjPress ReleaseOctober 3, 2018 at 9:00 a.m. (CET+1) Divestments and closing down certain business operations and sites will reduce Tikkurila’s personnel by 290 employees and other headcount reductions by 210 employees compared to the end of 2017. In addition, Tikkurila will temporarily lay off blue-collar workers in Finland.In 2017, Tikkurila initiated an extensive program to boost profitability. The program is aimed at generating at least EUR 30 million in savings. Improved cost competitiveness will support Tikkurila in seeking new growth opportunities. Closing down of

Eklund Foundation Announces 2018 Grant Recipients

The Eklund Foundation for Odontological Research and Education is pleased to announce the projects receiving this year’s grants of EUR 150,000. In 2018, the foundation has chosen to support two high-level scientific projects, conducted by prominent researchers within periodontology. “We proudly contribute to these two ambitious and well-designed studies on the cutting edge of periodontology, which is a research area of special priority to us. Both projects have the potential to bring deeper insight into a disease which afflicts millions around the world”, said Joel Eklund, Chairman of

There are no items matching the current filter
There are no more items matching the current filter
Back to top